We keep repeating that early cancer diagnosis has a positive effect on treatment outcomes. However, many people postpone the visit to the doctor due to the fact that some diagnostic procedures cause significant discomfort.
Fortunately, modern science is not standing still, and now it is possible to screen early bowel cancer using a non-invasive, safe and painless method of quantitative analysis of fecal hemoglobin and transferrin using the HTSA method. It is many times superior in sensitivity and specificity to the traditional fecal occult blood test and has a unique marker - transferrin, which allows detecting up to 30% of cancers in the ascending colon, previously unavailable for routine laboratory studies.
Thanks to this method, the detection rate of early cancer has increased by 30%. The accuracy of the method is 96% in patients with cancer and 88% in patients with precancerous conditions.
